Skip to main navigation Skip to search Skip to main content

Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future

  • Stacey J. Adam*
  • , Timothy G. Buchman
  • , Judith S. Currier
  • , Ruxandra Draghia-Akli
  • , Josh P. Fessel
  • , Elizabeth S. Higgs
  • , Eric A. Hughes
  • , Lisa Lavange
  • , Joseph P. Menetski
  • , Sarah W. Read
  • , Yves Rosenberg
  • , Randall Tressler
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

The Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent prioritization, preclinical therapeutics testing, master protocol design and implementation, drug manufacturing and supply, data sharing, and public-private partnership value are shared to inform responses to future pandemics.

Original languageEnglish
Article numbere150
JournalJournal of Clinical and Translational Science
Volume8
Issue number1
DOIs
StatePublished - 15 Oct 2024

Keywords

  • Covid-19
  • lessons learned
  • master protocol
  • therapeutics
  • trials

Fingerprint

Dive into the research topics of 'Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future'. Together they form a unique fingerprint.

Cite this